Skip to main content

400 Dialysis Centres on PPP model to push rural healthcare

Union Health Minister JP Nadda stressed upon need to promote PPP model for National Dialysis Scheme & diagnostic facilities for rural populace
Related Category:

Union Health and Family Welfare Minister JP Nadda urged private sector to join hands with government’s Public Private Partnership (PPP) model for three areas- Prime Minister Dialysis Scheme, Free Diagnostics facilities to rural people and strengthening of National Institute of Pathology.

Inaugurating a Scientific Symposium, organized by Dr Lal PathLabs to mark the 100th Birth Anniversary of its Founder, Dr (Maj) SK Lal, Nadda said, “The government is committed to take PM Dialysis Yojna to district level for free facility for BPL and 400 centres proposals on the PPP model from states have been approved. The government cannot do it alone and reputable & leading private players like Dr Lal PathLabs need to come together.”

Appreciating Dr Lal PathLabs’s immense contribution in the field of laboratory medicine, Union Health Minister said, “The government will provide full support to private players which have expertise, brand & credibility and can provide quality & affordable facilities to a large number of people.”

“PPP model would bring in great help to people of rural areas where Primary Healthcare Centres would have world class diagnostic facilities which would be free for BPL and affordable for APL & other categories. Government of India stands committed in this regard but due to lack of infrastructure the government healthcare units alone would not be able to cater the need,” he added.

To address the challenges of laboratory medicine in the country, Dr Lal PathLabs, the oldest and most reputed laboratory in India, organised a two-day Scientific Symposium which marks the 100th Birth Anniversary of its Founder, Dr (Maj) SK Lal. The two-day Symposium concluded today.

Dr Arvind Lal, Chairman & Managing Director of Dr Lal PathLabs said, “ Our PathLabs have become the most sought after brand in the field of Laboratory Medicine. We have reached this far by adhering to the highest standards of quality, service and ethics.”

“Today, we dedicate ourselves to strengthen our Research and Development (R&D) division to introduce low cost high-end tests for the economically weaker sections of our society and make them available to all our countrymen all over India,” he added.

During the sessions eminent national and international researchers, specialists and academia deliberated on topics related to Renal and Transplantation Pathology, Liquid Biopsies, Acute Leukemias and HSCT, newer innovations in Microbiology, Lab Management and Point of Care Testing, Diagnostics in Reproductive Genetics, Neuro Technology Advances in Diagnostics and Clinical Practice etc.

Experts said that it must be remembered that 70 percent of all clinical and medical decisions are made on the basis of pathology test reports.

Dr Lal PathLabs operates 175 laboratories, 1,600 sample collection centres and over 5,000 pickup points spreading all over the country. Last year they tested more than 1.24 crore patients and on a single day more than 50,000 patients get their tests done by them. The pathology behemoth offer the largest test menu of over 3,370 diagnostic tests.

Votes with an average with

Related Story

India Post ventures in e-commerce to support rural artisans

Minister of State for Communications (lndependent Charge), Manoj Sinha launched the e-commerce portal of the Department of Posts (DoP) Friday. The portal will provide an e-market place to sellers…

ENSURE portal to ensure livestock subsidies under DBT

Union Agriculture Minister Radha Mohan Singh launched a portal ENSURE- National Livestock Mission-EDEG developed by National Bank for Agriculture and Rural Development (NABARD) and operated under…

Kubota, Escorts to jointly manufacture high-tech tractors

Escorts, India’s leading engineering conglomerate and Kubota Corporation, Japan’s biggest and world’s leading tractor manufacturer announced their global joint venture Monday to manufacture high-…

The website encountered an unexpected error. Please try again later.